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Abstract  
 
Background: Low Back Pain (LBP) is common, however research comparing the 
effectiveness of different treatments over the last two decades conclude either no or 
small differences in the average effects of different treatments. One suggestion to 
explain this is that patients are not all the same and important subgroups exist that 
might require different treatment approaches. Stratified care for LBP involves 
identifying subgroups of patients and then delivering appropriate matched 
treatments. Research has shown that stratified care for LBP in primary care can 
improve clinical outcomes, reduce costs and increase the efficiency of health-care 
delivery in the UK. The challenge now is to replicate and evaluate this approach in 
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other countries health care systems and to support services to implement it in routine 
clinical care. 
 
Results: The STarT Back approach to stratified care has been tested in the National 
Health Service, within the UK, it reduces unnecessary overtreatment in patients who 
have a good prognosis (those at low risk) yet increases the likelihood of appropriate 
healthcare and associated improved outcomes for those who are at risk of persistent 
disabling pain. The approach is cost-effective in the UK healthcare setting and has 
been recommended in recent guidelines and implemented as part of new LBP 
clinical pathways of care. This approach has subsequently generated international 
interest, a replication study is currently underway in Denmark, however, some 
lessons have already been learnt. There are potential obstacles to implementing 
stratified care in low-and-middle-income settings and in other high- income settings 
outside of the UK, however, implementation science literature can inform the 
development of innovations and efforts to support implementation of stratified care. 
 
Conclusions: The STarT Back approach to stratified care for LBP is a promising 
method to advance practice that has demonstrated clinical and cost effectiveness in 
the UK. Over time, further evidence for both the effectiveness and the adaptations 
needed to test and implement the STarT Back stratified care approach in other 
countries is needed.  
 
 
Bullet Points 
 
• The STarT Back stratified care approach involves the use of a 
prognostic screening tool and matched treatments. 
• Two UK studies have demonstrated improved clinical outcomes and 
cost savings in the National Health Service.  
• Studies testing this approach in other countries are needed to adapt 
the approach to their own healthcare system.  
• A number of potential obstacles to implementing stratified care in high- 
and low-and-middle-income settings are emerging. 
• Evidence based innovations and strategies to overcome these 
obstacles and support successful implementation are discussed. 
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Introduction, rationale and key principles of stratified care 
 
First contact clinical care, or primary care, for most patients with low back pain (LBP) 
is provided by a range of clinicians such as family doctors/general practitioners 
(GPs), physiotherapists and chiropractors. The latest LBP clinical guidelines 
available 1, 2    generally recommend clinicians triage patients into either those with 
serious spinal pathology (estimated to be no more than 3-6% of LBP patients in 
primary care)3,4, nerve root problems (estimates include 36% with pain radiating 
below the knee)5 or non-specific LBP (the majority of cases). The last two decades 
have seen a considerable increase in the volume of research, particularly 
randomised controlled trials (RCTs) and systematic reviews6,7, comparing the 
effectiveness of different treatments for non-specific LBP. Many of these RCTs and 
systematic reviews conclude either no or small differences in the average effects of 
different treatments, such as exercise, manual therapy and other physiotherapist-led 
treatments. Whilst there are several potential explanations for these findings, one 
suggestion is that these are the result of the inclusion of heterogeneous groups of 
patients with non-specific LBP, that patients are not all the same and that important 
subgroups exist that might require different treatment approaches.8 
Stratified care involves targeting treatment to subgroups of patients with 
similar characteristics and has been suggested as a method to fast-track patients to 
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appropriate treatment by supporting clinical decision-making in ways that serve to 
increase treatment benefit, reduce harm and increase the efficiency of health-care 
delivery.9  LBP is an ideal clinical condition with which to develop and test models of 
stratified care, given that it includes a heterogeneous population of patients with 
substantial variability in prognosis,10 and that numerous treatments are available9  
with some being costly and associated with high risk (e.g. spinal surgery). Further 
justification for considering stratified care approaches include the finding that most 
clinicians believe that non-specific LBP includes a number of distinct patient 
subgroups11 and that due to the sheer volume of patients attending primary care with 
LBP it is impractical and unaffordable to refer all for expensive tests and 
treatments.12 
There are several broad approaches to stratified care for LBP, those which 
start with the patient and identify characteristics of patients with which to subgroup 
them (most commonly using their prognostic profile, key characteristics or an 
underlying cause or mechanism that is thought to explain their symptoms) or those 
which start with available treatments and identify patients that appear to benefit more 
from one treatment over others (most commonly through the development and 
testing of clinical prediction rules). These different approaches have been considered 
in more detail elsewhere.13 A team at Keele University in the UK have over the last 
15 years developed and tested a model of stratified care based on subgrouping and 
targeting treatment for LBP. Their work has produced a primary care prognostic 
model in which multiple clinical predictors are used in one simple index of risk (the 
Keele STarT Back Tool (KSBT)) to identify an individual’s risk of persistent disabling 
LBP and then matches those at low, medium and high risk to appropriate treatments. 
 
The Keele STarT Back Tool 
 
The KSBT is a prognostic tool developed and validated for use in primary care to 
guide the management of patients with LBP.14 It has nine items that screen for eight 
physical and psychological predictors of persistent disabling LBP six months later. 
These questions are summed into an index score with defined cut-points to identify 
those at low, medium, or high risk of persistent disabling LBP. The tool has good 
reliability and validity and has been externally validated in many different settings.15-
18 Clinicians need to interpret the findings of the KSBT in the context of a standard 
LBP subjective and objective assessment, including a screen for serious pathology 
(red flags) and a neurological examination. Clinicians can freely download the tool (in 
a range of languages) from the STarT Back website.19 This model of stratified care 
comprises not only the use of the tool but also of matched treatments for each risk 
subgroup. 
 
The matched treatments 
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An outline of the three matched treatments is provided below, further information 
about the development of the STarT Back matched treatments and the associated 
physiotherapy training and mentoring packages can be found in Sowden et al, 2012, 
Main et al, 2012,20-21 and on the STarT Back website.19 
The low risk matched treatments 
The matched treatment for patients at low risk of persistent disabling LBP consists of 
one high quality face to face consultation in which patients are reassured regarding 
the benign nature of low back pain and its prognosis. Education and advice should 
focus on positive self-management messages about avoiding bed rest, using 
appropriate pain medications, keeping active and returning to usual activities, 
including work or daily routines, as soon as possible. These messages are 
supplemented and reinforced by evidence based written or online material (e.g. in 
the UK, the Arthritis Research UK’s advice/exercise sheet).22 Patients are discharged 
after this one-off consultation, thereby avoiding onward referral, unnecessary 
imaging, sick certification, or strong opioid medication. The data from two UK studies 
(the STarT Back trial and IMPaCT Back study) suggests that patients at low risk who 
receive this matched treatment package have pain and function outcomes that are 
no worse than patients at low risk who go onto receive additional treatments. In fact, 
for some outcomes, such as time-off-work outcomes were better in those who 
received stratified care. In addition, the data shows that the healthcare system 
benefits from greater efficiency and reduced costs from not over-medicalising these 
low risk patients. This is in keeping with studies in whiplash patients, which suggest 
that more treatment is not necessarily better23 and can in fact lead to worse 
outcomes for some patients.24-26 However, clinicians should note that the KSBT aims 
to assist first-line treatment decision-making and not replace it. Secondary analyses 
of the STarT Back trial by Beneciuk et al (2017)27 also suggests that low risk patients 
with low socio-economic status (SES) were more likely to have a poor outcome than 
patients with high SES.         
 The matched treatment for patients at medium risk involves a course of 
evidence based physiotherapy. In addition to the low risk intervention package, 
patients at medium risk should receive physiotherapy aimed at reducing pain and 
disability and promoting self-management of the current episode of LBP, as well as 
future episodes. The course of physiotherapy includes advice, explanation, 
reassurance, education, exercise (specific and/or general) and if appropriate, manual 
therapy. Bed rest, traction, massage and electrotherapy are not generally 
recommended and were not part of the protocol for patients at medium risk in the UK 
studies of stratified care. Where indicated, a small proportion of patients can be 
referred for investigations or specialist interventions.28 
The high risk matched treatments 
The treatment for patients at high risk involves similar evidence based assessment 
and management (e.g., advice regarding medication and exercises and manual 
therapy, as indicated) to that given to medium risk patients. However, these physical 
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approaches are integrated with psychological approaches to treatment. The phrase 
‘psychologically informed practice’ (PIP) was coined to reflect this biopsychosocial, 
cognitive behavioural physiotherapy treatment approach.21 The physiotherapists 
treating patients at high risk in the STarT Back trial and IMPaCT Back study received 
six days training in PIP. The training focussed on the use of enhanced 
communication skills to build rapport and trust with patients and to establish 
expectations and agree objectives for treatment. The physiotherapists were trained 
to validate and normalise patient’s experiences and to adopt motivational 
interviewing techniques to maximise treatment effectiveness. They conducted a 
comprehensive biopsychosocial assessment to identify the helpful and unhelpful 
ways in which patients were responding to their pain and the impact of pain on 
current functioning (physical, psychological and social). They were expected to use 
clinical reasoning to make sense of complex assessment findings, identify the key 
issues for individuals, differentiate (where possible) between pain-related and non-
pain-related distress and to determine what was or was not modifiable. The patient’s 
values based goals were used to guide treatment. Where patients had persistent 
pain despite trying sensible treatments, then therapists were expected to shift the 
agenda away from providing further treatment aimed at pain reduction and towards 
efforts focussed on improving quality of life and functioning, with pain. The 
physiotherapists were also trained to utilise cognitive (e.g. reassurance; education; 
providing a neurophysiological/central sensitisation pain explanation) and 
behavioural techniques (e.g. behavioural analysis; exposure; behavioural 
experiments). In determining when and which of these techniques to adopt they were 
encouraged to consider the purpose of treatment and likely effectiveness for the 
individual. In addition, the physiotherapist identified and addressed obstacles to 
remaining or returning to work (e.g. developing and implementing a return to work 
plan) and provided simple evidence based advice and information aimed at 
improving sleep pattern, quality and quantity.      
       
 
Testing the stratified care approach UK: STarT Back Trial and 
IMPaCT Back study  
 
The programme of stratified primary care research for LBP commenced with the 
publication of the KSBT in 2008,14 the STarT Back trial in 2011,5,28 and the IMPaCT 
Back UK implementation study in 2014.29,30        
The STarT Back trial involved 851 adults with LBP from 10 general practices 
in England, with patients randomly assigned in a 2:1 ratio to stratified care 
(intervention group; n=568) or current best care (control group; n=283). LBP-specific 
disability measured using the Roland and Morris Disability Questionnaire (RMDQ),31 
was the primary outcome measure. Cost effectiveness was evaluated by comparing 
the quality adjusted life years (QALYS) and health-care costs of the intervention and 
control group. The trial results showed that at both 4 months and 12 months, patients 
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in the intervention group (who had matched treatments based on their KSBT risk 
subgroup) had significantly greater improvements in disability scores compared with 
those in the control group.5 In addition, the intervention group were more likely to 
report reduced fear of movement, less depression, better general health, were more 
satisfied with their treatment and had taken fewer days off work because of LBP. 
Patients at low risk received fewer investigations, imaging, and referrals to 
secondary care, and patients in the medium and high risk subgroups were offered 
evidence based physiotherapy (medium risk) or psychologically informed 
physiotherapy (high risk). This stratified care approach also resulted in a greater 
health benefit that was achieved at a lower average health-care cost, with an 
average saving of £34.39 per patient.28 The STarT Back trial provided high quality 
evidence that a stratified care approach significantly improves patient outcomes and 
is associated with substantial economic benefits compared with current best 
practice. The approach seemed to be working by changing which patients were 
referred for physiotherapy treatment in a manner that was more in line with patient 
prognosis, ensuring patients at low risk were not over-treated unnecessarily and that 
patients at high risk were provided with a combined physical and psychological 
intervention in a timely manner. In addition, Mansell et al (2016)32 used a mediation 
analysis to investigate whether pain and psychological distress were mediators of 
the effect of the matched treatment for patients at high risk in the STarT Back trial. 
They demonstrated not only the strong correlation between changes in pain and 
distress and changes in LBP disability but importantly demonstrated that the training 
provided to upskill the physiotherapists to deliver a combined physical and 
psychological programme significantly improved the therapists’ abilities to achieve 
changes in pain and distress with patients at high risk.     
 The research team at Keele also conducted a large implementation study 
called the IMPaCT Back study29 to investigate whether the STarT Back stratified 
care approach could be implemented into busy, routine primary care and to study the 
effects of doing so on patients’ outcomes, costs and healthcare process outcomes. 
The study used a sequential comparison before and after study design among 64 
general practitioners (GPs) and linked physiotherapy services and 922 patients. GP 
consultations were enhanced by the use of the KSBT in the consultation. GPs were 
also encouraged to manage patients at low risk themselves and only refer patients at 
medium and high risk to physiotherapists, where they then received the appropriate 
matched treatment (as in the STarT Back trial). The primary outcome was again 
LBP-specific disability (RMDQ) and in addition, the study captured changes in 
clinician behaviours and particularly in treatment decision making such as referrals to 
physiotherapy, imaging, medication prescriptions, and sickness certifications. A cost-
utility analysis again estimated incremental quality-adjusted life years and back-
related healthcare costs. Results of the IMPaCT Back study showed small but 
significant improvements in LBP disability scores and large and important reductions 
in time-off-work (reduced by 50% overall from a mean of 8 to 4 days), without 
increasing healthcare costs. The study demonstrated that stratified care changed 
clinician treatment decisions for the better, with greater proportions of patients at 
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medium and high risk of persistent disabling LBP being referred to physiotherapy. 
 Following publication of the STarT Back and IMPaCT Back results there has 
been a great deal of international interest in the STarT Back approach to stratified 
care for LBP. As a consequence, a number of international research teams have 
sought to replicate the UK results, with one study to date having reported positive 
results in Ireland33 and a further six studies in progress. Over 1000 studies that have 
cited the KSBT or trial papers, and many studies have tested the predictive abilities 
of the tool in a range of clinical settings (e.g. chiropractic, secondary care and the 
emergency department), 34,18 with different types of patients (acute, chronic) and in 
many different countries.34-40 The learning from these studies include a realisation 
that unsurprisingly the KSBT predicts some outcomes (e.g. LBP disability for which it 
was developed to predict) better than others (e.g. patient satisfaction), that its 
prediction has a ‘sweet spot’ in terms of timing, being less predictive in patients with 
less than two weeks LBP duration, and less predictive among patients with chronic 
LBP (more than 3 months), and that the tool predicts observed mean outcome and 
not change in outcome. 
The stratified care research team at Keele University are currently delivering a 
new programme of research to test whether a similar prognostic model of stratified 
care might be effective for patients with the five most common musculoskeletal pain 
presentations in primary care (back, neck, shoulder, knee and multi-site pain). The 
new Keele STarT MSK Tool41 is in external validation stages and is expected to be 
published in 2018. A clinical trial to test the new STarT MSK stratified care approach 
in UK primary care is in progress. The team are also delivering the SCOPiC clinical 
trial,42 which is testing the clinical and cost-effectiveness of stratified care (combining 
prognostic risk stratification with clinical indicators of severity) for patients with 
sciatica.  
 
 
Testing the stratified care approach in Denmark 
 
In 2010, the KSBT was translated into Danish and validated in a Danish population43- 
45 and then in 2015, funding was obtained to conduct a broad replication of the 
STarT Back trial in Denmark. The trial is currently underway. The key steps in this 
journey, the progress made to date and key lessons are outlined below. 
 
Translation and Validation of the Keele STarT Back Tool 
The process of translating the KSBT followed international standards.46,47 The 
Danish version was then piloted among patients with LBP. In addition, the 
discriminative ability of the translated Danish version was tested. Seven of the nine 
items, where reference standards were available, were compared to the original 
English version. The translated version was found to be linguistically accurate, 
acceptable to patients and had sufficient discriminative validity to recommend it’s use 
in Denmark.45  
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Predictive ability 
In 2012, two studies tested the predictive ability of the Danish STarT Back tool in 
both primary and secondary care settings, within the Danish Healthcare System. The 
Danish version was able to predict a similar relative risk for poor outcome on activity 
limitation in the Danish primary care cohort in the low and medium risk subgroups, 
but was a little less predictive in the high risk subgroup. Although still significant, the 
Danish STarT Back Tool had less predictive ability in a Danish secondary care 
cohort.43,44 
 
Replication of the stratified care approach in a Danish primary care setting 
In 2015, the Danish research team commenced testing the stratified care approach 
used in the STarT Back trial5 in the regions of Southern and Central Denmark. They 
engaged Danish GPs and physiotherapists to participate in the study and considered 
the practicalities of conducting the trial within the existing Danish healthcare 
services. The stratified care approach needed to be integrated within the existing 
Danish clinical pathway and needed to be consistent with the Danish regional 
guidelines (e.g., targets for the time taken between referral to physiotherapy and the 
patient being seen). Attention was also paid to identifying and overcoming potential 
obstacles to testing stratified care in Denmark, these included inadequate clinician 
knowledge and skills, limited consultation time and the need to have patient 
resources in the Danish language. The physiotherapists delivering the intervention 
arm of the trial received training to deliver the matched treatments from the Keele 
University trainer. Supervision of these physiotherapists for the duration of the trial 
was conducted in small groups and was facilitated by physiotherapists who had 
previously attended the Keele stratified care course, had received training from a 
psychologist and had experience of putting the approach into practice with patients. 
Patients in the intervention arm received a booklet in Danish containing similar 
messages to the booklet used in the STarT Back Trial and a web address to a 
patient video developed by the Keele team, a private healthcare provider (AXA PPP) 
and a professional film company, subtitled in Danish. 
 
Design 
The Danish trial of stratified primary care for LBP (article submitted) consisted of a 
randomised controlled trial in primary care involving ten cities. Patients were 
recruited by GPs, when they consulted with an episode of non-specific LBP. The 
GPs assessed and electronically referred patients to private physiotherapy clinics. All 
patient’s referred to physiotherapy completed the Danish STarT Back tool online 
before their first physiotherapy appointment. In each city, a matched pair of 
physiotherapy clinics was randomised. The physiotherapists in one clinic delivered 
the intervention arm. They were informed of the patient’s Danish STarT Back Tool 
score and risk subgroup and were to deliver the matched treatments. The 
physiotherapists in the control arm did not have access to the patient’s STarT Back 
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tool results, did not receive any matched treatment training and were expected to 
deliver current practice.  
 
Outcome measures 
The primary outcomes in the trial are time off work, LBP-related disability measured 
by the RMDQ31 and patient reported global change. Secondary outcomes are pain 
intensity, patient satisfaction, data on patient health care resource utilization and 
health care costs. Referrals to secondary care are also being monitored. 
Lessons learnt to date 
This Danish trial has just completed patient recruitment (n=333), patient follow up is 
ongoing, however the research team have already learnt a number of things. In 
Denmark GPs and physiotherapists are privately funded, therefore, although their 
participation in the trial is funded, it is very difficult for them to engage in research 
over a longer period, due to workload and competing interests. Recruitment of 
patients to the study was slow, this might have had an adverse impact on treatment 
fidelity as each clinician may need to see a number of patients throughout the trial in 
order to develop and maintain their skills and confidence in delivering the treatment 
approach. Shorter recruitment and treatment periods, a greater throughput of 
referrals and more regular contact with the research team might enhance fidelity to 
the treatment approach. Most physiotherapists delivering the intervention arm stated 
that the approach was useful for other musculoskeletal patients as well as ones with 
low back pain. In the trial, the researchers chose to match two clinics in the same 
city and randomize patients to either intervention or usual care. As a result, there is a 
possibility of contamination, particularly as the physiotherapy profession in Denmark 
is quite small and the study has received some publicity.    
 If this replication trial produces promising results it is hoped that stratified care 
for LBP will form part of the national Danish implementation strategy for evidence-
based LBP care in primary care. If so, it is advisable to use existing frameworks for 
implementation and evaluation of studies, given the complexities of research and 
clinical practice.  
 
 
Implementation of stratified care (STarT Back)  
 
It is widely acknowledged that adoption rates for complex interventions are low and 
that there is often a knowledge-to-practice gap. Poor or ineffective implementation 
appears at least partly, to explain this.48 Unfortunately, healthcare which does not 
integrate evidence not only runs the risk of harm but also misses the opportunity to 
benefit patients.49 An Impact Acceleration Unit (IAU) has been established within the 
Research Institute for Primary Care & Health Sciences at Keele University in the UK, 
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tasked with supporting the implementation of key musculoskeletal research findings 
into policy and practice. To date, this has primarily involved supporting healthcare 
systems, services and clinicians to implement stratified care within the UK NHS. 
Throughout this process, the IAU has worked in conjunction with healthcare 
purchasers and providers to understand potential barriers and design solutions to 
enhance implementation, taking account of their specific context.  
 Whilst, no single strategy is likely to work and innovations and strategies may 
need to be adapted to suit different groups or contexts (e.g. because of different 
patient population needs, health care services or resources),48 the IAU has drawn on 
the implementation and knowledge mobilisation science literature when developing 
innovations and supporting services to implement them. Unfortunately, there isn’t a 
one-size-fits-all, step-by-step instruction manual for implementation, as 
implementation is difficult and takes place in a complex environment,49 however the 
below evidence based implementation innovations and strategies, if adapted and 
adopted flexibly, may well support successful implementation of stratified care, in 
different health care contexts. Further information about these and other innovations 
and resources, most of which are freely available, can be found on the STarT Back 
website.19 
 
Identify the evidence to practice gap 
 
If stratified care for LBP is going to be implemented into policy and/or practice, it is 
important to have a good understanding of the STarT Back and IMPaCT Back 
study’s research design, interventions delivered and results. Next it is important to 
determine to what extent the KSBT is currently being used in the local LBP 
population, what proportion of patients are classified as at low, medium or high risk 
and how they are currently being managed. It should then be possible to identify any 
gap, in other words, to determine in what ways current clinical practice is similar or 
different to what was done in the research study. Whilst stratified care is more likely 
to be successfully implemented if it is adapted to suit the local context, population 
needs, financial and other resource constraints, it is important to stay as close to 
what was done in the research studies as possible, otherwise there is as risk that 
whilst something is being implemented, it is not necessarily being implemented with 
fidelity or in keeping with the evidence. 
 
Identify and engage your key stakeholders  
Stakeholders may include managers and providers of services, users of services and 
carers, as well as purchasers of services. It is important to identify and actively 
engage your key stakeholders early in the process of implementation and decision-
making by utilising existing relationships and by building relationships where non 
exist. The mechanisms through which you engage your stakeholders may vary (e.g. 
opportunistic conversations, formal meetings, being introduced by others) and you 
may need to ‘flex’ the message depending on the target audience. Different 
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audiences may be more receptive to people from a particular professional 
background or role, so it can also be advantageous to have different professional 
backgrounds and roles represented within the wider implementation team.   
 
Consider how and where stratified care fits into the Organisation and wider context 
 
It may be necessary to ‘sell’ the benefits of stratified care and to seek the 
endorsement of clinical and other organisational stakeholders. An organisation, 
healthcare economy and or government are more likely to modify or adopt a new 
system, process or practice if it is aligns to contemporary standards, current policy 
and legislation. Consideration should be given to how implementing stratified care 
and potentially improving clinical outcomes, improving health care efficiency, 
reducing health care utilisation, increasing clinician knowledge and skills or 
increasing patient satisfaction, might address some of the challenges within the local 
health care system. It may be useful to cite international and national policy and 
practice documents in which STarT Back has been recommended, for example, in 
2016, the updated NICE LBP guidelines2 and the National Back Pain Pathway50 in 
the UK recommended use of stratification tools including the Keele STarT Back Tool 
and a recent Public Health England51 document outlined the cost effectiveness of 
implementing stratified care in the UK. Stratified care is now also part of the recently 
developed low back and radicular pain pathway in Belgium.52 It may be helpful to 
have a suit of ‘evidence’ as different types of ‘evidence’ such as research findings, 
audit data, patient stories or guidelines may influence different types of stakeholders.  
If developing a business case, (see STarT Back website for a draft business case 
template), be mindful of the economic/financial climate locally and nationally when 
detailing the resource required (cost, return on investment, ‘opportunity cost’), 
wherever possible use policy language and make it as easy as possible to 
implement (highest return for lowest investment).  
 
Agree the care pathway 
 
Implementation of research findings may impact on existing workflows, systems and 
processes within the organisation. Stratified care is a systems approach, so whilst it 
can be implemented within a physiotherapy service, it is best implemented at the 
most appropriate point within the patient clinical pathway. This may require a new 
pathway or a revision of an existing one, either way, it is helpful to be able to answer 
the following questions. 
• At what point(s) will the KSBT be completed and how will this be done (e.g., 
phone, post, in person)? 
• Who will manage the patients at low risk and how will unnecessary over-
treatment be prevented? 
• How will PIP be delivered to patients at high risk? 
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Engage patients and the public 
 
Engaging the patient and public can help ensure that pathways of care are relevant, 
feasible and acceptable to the people who will be using the clinical services. Service 
users have a unique view of clinical provision and can give valuable insight into how 
experiences and services could be improved. One of the innovations that the IAU 
has supported, is the co-production of a patient information leaflet for patients with 
back pain. It has been written by patients, illustrated with patient stories and 
underpinned by the latest research evidence.53  
 
 
Specify the behaviour change needed and the health care professional group(s) 
whose behaviour needs changing. 
 
Consider how the new intervention influences or fits with the clinicians role e.g. will 
clinicians see use of the tool and matched treatments as congruent with their role, 
style of practice, personal interests and their consultation workflow? Ensure as much 
as possible that stratified care has good integration with existing systems and 
workflows, and is adaptable to the local context (e.g., population needs, healthcare 
setting, expertise and number of clinicians). Consider innovations that might make it 
easier for busy clinicians to integrate the KSBT into their consultations. For example, 
the IAU, in collaboration with GPs developed an electronic e-tool (the StarT Back 
EMIS tool). This is embedded within GP clinical computer systems, facilitates the 
completion of the SBST within busy GP consultations and guides the GP in providing 
evidence based stratified care. It also has a simple electronic referral to 
physiotherapy and a patient information leaflet integrated into it. 
 
 
Identify the obstacles and solutions to implementation 
It is important to consider contextual, organisational, professional and intervention 
factors when considering potential barriers and solutions to implementation as 
implementation success appears to be influenced by these four factors. For 
example, potential barriers to implementing stratified care in the UK, included GPs 
reporting insufficient time in the consultation to use the KSBT, a difficulty integrating 
it into their usual workflow and challenges around assessing patients for red flags. 
The IAU has therefore developed a video of a model first contact consultation 
between a GP and a LBP patient in which the tool is introduced and completed. The 
IAU also put information about examining LBP patients and identifying red flags on 
the STarT Back website and a link to a video presentation about red flags and LBP is 
also available on u-tube.54 The IAU are aware that clinicians can find it challenging 
to deliver the matched treatments so they have developed a number of resources to 
assist with this. For example, they have outlined the clinician behaviours that are 
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desirable in delivering stratified care (Desirable Clinician Behaviours) and have 
developed a method whereby clinicians in the same geographical area might come 
together and support each other to manage high risk patients. This has been termed 
‘Peer Practice Based Support’ and a number of documents relating to this can be 
found on the STarT Back website. The IAU continue to deliver training courses for 
physiotherapists, however, in order to meet the challenge of delivering training at 
pace and scale, we are considering the development of a ‘train the trainers’ course. 
Another barrier identified by the IAU was the cost to clinical services of the patient 
DVD and leaflets that were used in the STarT Back and IMPaCT Back trials so the 
IAU and a private health care provider (AXA PPP) commissioned a professional film 
company to produce a high quality patient DVD called ‘The Truth About Back Pai,.55 
which is freely available. 
 
Devise a strategic implementation plan 
 
The next step might be to work with key stakeholders, including a user reference 
group to collaboratively devise an implementation plan and support its delivery. 
Ideally, this would include realistic, measurable and co-ordinated goals and 
milestones, clearly defined roles and responsibilities and clarity about the required 
resources for all stages (e.g., funding; adequate staff with appropriate skills; training 
and ongoing support) and details of how to provide these resources.49 The resources 
needed may however vary, depending on the phase and scale of implementation.  
 
Engage the workforce 
 
The success of implementation will in large part be determined by the extent to 
which key internal and external stakeholders engage in the process. Local clinical 
champions can influence key professional groups and can find practical solutions to 
overcome obstacles and help implement them. Evidence suggests ‘…spread 
depends on more than good ideas and willing adopters…it is a complex social 
process’56 so it may be advantageous to develop and engage networks and 
communities of practice. Physiotherapy champions and partnerships have resulted in 
stratified care being successfully embedded within a number of clinical pathways in 
the UK (e.g., Stoke on Trent, Birmingham, Salford and Gloucestershire).57 
 
 
Identify how you will measure success  
It is desirable to identify measures of success (e.g. pre and post clinical outcomes, 
process measures, healthcare utilisation and costs, patient, referrer and clinician 
experience) and establish how these will be assessed. The Keele IAU have 
developed an audit tool which is free to download and use and they recommend the 
use of a recently published generic musculoskeletal patient reported outcome 
measure called the MSK-HQ.58 For permission to use this questionnaire, please 
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contact:https://innovation.ox.ac.uk/outcome-measures/musculoskeletal-health-
questionnaire-msk-hq/. Lastly, agree a ‘go live’ date, evaluate the effects of your 
implementation, share experiences and learning, and celebrate your success.   
 It is becoming clear that the implementation of this stratified care approach 
(using both the tool and matched treatments) in some countries is challenging, either 
because treatments are largely driven by patient choice or the types of matched 
treatments that best address the needs of patients at medium or high risk of 
persistent disabling pain are not available. In some countries where a private model 
of healthcare dominates, there are strong financial incentives for over-treating 
patients at low risk. A further issue is the lack of high quality training available to 
upskill physiotherapists to feel confident at offering the psychologically informed 
physiotherapy intervention for patients at high risk. To help those in other countries 
who might be considering whether and how to implement stratified primary care for 
low back pain, in particular those in low-and-middle-income settings, the following 
section considers the example of Africa. 
 
 
South African and Regional Perspectives  
 
The burden of LBP is growing considerably in low-and-middle-income regions such 
as Africa. In sub-Saharan Africa LBP is a leading cause of disability and among the 
most common reasons for visiting a primary care facility.59 Despite this, there are no 
documented efforts by government departments to improve the efficiency and cost-
effectiveness of the management of LBP in Africa. This is arguably because the 
focus of health targets in regions such as Africa is on saving lives instead of 
improving quality of life. However, there is increasing acknowledgment of morbidity 
as the burden of disease is transitioning from communicable disease mortality to 
communicable and non-communicable disease morbidity. Hopefully, this will trigger 
more action towards optimising health and cost outcomes for people with conditions 
such as LBP.     
The management of LBP in Africa remain fragmented, non-standardised, not 
based on evidence and primarily relies on the opinion and clinical judgement of each 
individual clinician.60 In many low-income countries, the basic diploma level of 
physiotherapy training does not cover the assessment of musculoskeletal conditions 
such as LBP. There are also extremely limited continuous professional education 
opportunities for these physiotherapists to upskill themselves as there are no or very 
few clinical leaders in these countries. High-and-middle-income countries such as 
South Africa play an important role in steering the education and training of 
physiotherapists treating LBP in Africa.  Goal oriented, collaborative linkages with a 
focus on education between low-and-middle income countries is an important 
stimulus to improve the care of LBP and to assess the feasibility of stratified care for 
LBP in Africa.      
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The healthcare systems in African countries are complex and constrained by 
financial and dire workforce shortages. High levels of inequality prevail in many 
African countries. For instance, in South Africa, there are two systems i.e. the public 
and private system. The inequality between these two systems is of great concern as 
80% of people depend on the public system while there are significantly more 
financial resources within the private system.61 Currently, the public and private 
systems operate as two, separate, parallel systems of healthcare. In the private 
sector, private medical insurers are eager to apply cost-effective strategies such as 
stratified care for LBP. Implementation of stratified care for LBP is therefore likely to 
be feasible within the immediate and short-term within the private system, provided it 
is supported by the medical insurer and adapted appropriately for the local 
population. Implementation within the public healthcare system in African countries 
will be challenging. The first challenge is the ability to advocate for the improved care 
of musculoskeletal conditions such as LBP. This will require leading researchers, 
clinicians, and other knowledge brokers to develop collaborations with influential 
stakeholders who can facilitate healthcare system changes. At primary care level, all 
patients with LBP are initially seen by a primary care nurse or medical doctor. Since 
the disease profiles of patients are complex and multi-morbid, LBP is not usually a 
priority during the less than five minute consultation. The referral rate to a 
physiotherapist (if available at the primary care facility) is very low.62 These barriers 
to the implementation of stratified care for LBP can potentially be addressed by 
strategies such as improved communication and patient education to improve 
referral of LBP patients to physiotherapists.   However, there must also be increased 
pressure on governments in low-and-middle income countries to respond to the call 
by the World Health Organisation by increasing the number of rehabilitation workers 
to improve the care of LBP.62 In many low-and-middle income countries there is only 
one rehabilitation worker for one million people.  However, due to resource 
constraints, improvements in human resources may not be realised within the 
immediate or short-term. Therefore, an alternative consideration is to implement the 
stratified care approach (or a contextualised version) into the content and training of 
evidence-based guidelines available for primary care nurses.63  
 Although there are strategic goals from African departments of health to 
encourage patient self-management, this remains challenging, given the low levels 
of education, poor compliance, and cultural context. In addition, there are many 
social problems such as unemployment, low levels of health literacy, the value 
placed on traditional healers, crime/war, political instability, poverty, reliance on 
social grants, less than ideal physical infrastructure for wellness and inadequate 
inter-sectorial integration. Therefore stratified care for LBP in Africa will likely first 
need to be adapted to suit local contexts before wider implementation is considered. 
High quality research will help identify and quantify the need for improved 
care models for LBP in Africa, identify the African and local context specific 
obstacles to implementation and how to overcome them and then test out one or 
more implementation approaches. 
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Summary 
 
LBP is common and LBP related disability is increasing, highlighting the need for 
new models of healthcare that ensure that LBP patients receive less of the wrong 
sort of care and more of the right sort of care. In this paper, we have introduced and 
explained a relatively new model of primary care developed in the UK for patients 
with non-specific LBP, based on patients’ risk of persistent disabling pain, called the 
STarT Back stratified care model. It involves two key components, first use of a short 
tool, the KSBT, to identify patients as at low, medium or high risk of persistent 
disabling pain and secondly application of matched treatments for each subgroup. 
The evidence from two studies (a randomised trial and an implementation study) in 
the UK is that this new approach to care reduces unnecessary overtreatment in 
patients who have a good prognosis (those at low risk) yet increases the likelihood of 
appropriate healthcare and associated improved outcomes for those who are at risk 
of persistent disabling pain. The approach has been shown to be implementable and 
cost-effective in the UK healthcare setting, is being recommended in recent 
guidelines and new LBP clinical pathways of care and had generated international 
interest. We have therefore, through this paper, also shared experiences from 
examples of teams in other countries who are currently testing this stratified care 
approach for LBP or who are, for the first time, considering whether this new model 
of care might be implementable in their own healthcare setting. We have provided 
key points of learning from the UK based team and from other countries that 
represent both high- and low-and-middle-income settings. As further studies (both 
research trials and implementation studies) are conducted, the evidence for both the 
effectiveness and the adaptations needed to the STarT Back stratified care approach 
will become clearer. 
 
Acknowledgements  
 
 
We thank the members of the Impact Accelerator Unit, in particular, Kay Stevenson 
(Senior Knowledge Mobilisation Fellow) who commented on part of a late draft of the 
manuscript. 
 
References  
 
1. Wong JJ, Cote P, Sutton DA, et al. Clinical practice guidelines for the 
noninvasive management of low back pain: A systematic review by the 
Ontario Protocol for Traffic Injury Management (OPTIMa) Collaboration. Eur J 
Pain. 2017; 21: 201-16. 
18 
 
2. NICE guideline [NG59] Low back pain and sciatica in over 16s: assessment 
and management. November 2016 (https://www.nice.org.uk/guidance/ng59 
3. de Schepper EI, Koes BW, Veldhuizen EF, Oei EH, Bierma-Zeinstra SM, 
Luijsterburg PA. Prevalence of spinal pathology in patients presenting for 
lumbar MRI as referred from general practice. Fam Pract. 2016; 33(1): 51-6. 
4. Enthoven WT, Geuze J, Scheele J, Bierma-Zeinstra SM, Bueving HJ, Bohnen 
AM, Peul WC, van Tulder MW, Berger MY, Koes BW, Luijsterburg PA. 
Prevalence and "Red Flags" regarding specified causes of back pain in older 
adults presenting in general practice. Phys Ther. 2016; 96(3): 305-12. 
5. Hill JC, Whitehurst DG, Lewis M, Bryan S, Dunn KM, Foster NE, Konstantinou 
K, Main CJ, Mason E, Somerville S, Sowden G, Vohora K, Hay EM. 
Comparison of stratified primary care management for low back pain with 
current best practice: (STarT Back) [ISRCTN37113406]: a randomised 
controlled trial. Lancet, 2011; 378(9802): 1560-71 [33.63] 
6. Marin TJ, Van Eerd D, Irvin E, Couban R, Koes BW, Malmivaara A, van 
Tulder MW, Kamper SJ. Multidisciplinary biopsychosocial rehabilitation for 
subacute low back pain. Cochrane Database Syst Rev. 2017: 
28;6:CD002193.  
7. Chou R, Deyo R, Friedly J, Skelly A, Hashimoto R, Weimer M, Fu R, Dana T, 
Kraegel P, Griffin J, Grusing S, Brodt ED. Nonpharmacologic Therapies for 
Low Back Pain: A Systematic Review for an American College of Physicians 
Clinical Practice Guideline. Ann Intern Med. 2017; 166(7): 493-505. 
8. Hancock MJ, Hill JC J Are Small Effects for Back Pain Interventions Really 
Surprising? Orthop Sports Phys Ther. 2016;46(5):317-9. 
9. Hingorani AD, Windt DA, Riley RD, Abrams K, Moons KG, Steyerberg EW, 
Schroter S, Sauerbrei W, Altman DG, Hemingway H; PROGRESS Group. 
Prognosis research strategy (PROGRESS) 4: stratified medicine research. 
BMJ. 2013; 346: e5793. 
10. Kongsted A, Hestbæk L, Kent P. How can latent trajectories of back pain be 
translated into defined subgroups? BMC Musculoskelet Disord. 2017; 18(1): 
285.  
11. Kent P, Keating J. Do primary-care clinicians think that nonspecific low back 
pain is one condition? Spine. 2004; 29(9): 1022-31. 
19 
 
12. Jordan KP, Kadam UT, Hayward R, Porcheret M, Young C, Croft P. Annual 
consultation prevalence of regional musculoskeletal problems in primary care: 
an observational study. BMC Musculoskelet Disord. 2010; 11: 144. 
13. Foster NE, Hill JC, O'Sullivan P, Hancock M. Stratified models of care. Best 
Pract Res Clin Rheumatol. 2013; 27(5): 649-61. 
14. Hill JC, Dunn KM, Lewis M, Mullis R, Main CJ, Foster NE, et al. A primary 
care back pain screening tool: identifying patient subgroups for initial 
treatment. Arthritis Rheum. 2008;59(5):632–41. 
15. Traeger a, McAuley JH. STarT Back Screening Tool. J Physiotherapy. 2013 
Jun;59(2):131. 
16. Morsø L, Kent P, Albert HB, Hill JC, Kongsted A, Manniche C. The predictive 
and external validity of the STarT Back Tool in Danish primary care. European 
Spine Journal. 2013; 22 (8): 1859-67. 
17. Medeiros FC, Costa LOP, Added MAN, Salomao EC, Costa LDCM. 
Longitudinal monitoring of patients with chronic low back pain during physical 
therapy treatment using the STarT Back Screening Tool. J Orthop Sports 
Phys Ther. 2017; 47(5):314-323. 
18. Medeiros FC, Costa LOP, Oliverio IS, Oshima RK, Costa LCM. The use of 
STarT Back Screening Tool in emergency departments for patients with acute 
low back pain: a prospective inception cohort study. Eur Spine J. 2018; April 
18. Doi: 10.1007/s00586-018-5586-0. 
19. The Keele STarT Back website. https://www.keele.ac.uk/sbst/. Accessed 
02.02.2018. 
20. Sowden G, Hill J, Konstantinou K, Khanna M, Main C, Salmon P, Somerville 
S, Wathall S, Foster NE  Subgrouping for targeted treatment in primary care 
for low back pain: the treatment system and clinical training programmes used 
in the IMPaCT Back study (ISRCTN 55174281). Fam Pract. 2012 
Feb;29(1):50-62. 
21. Main CJ, Sowden G, Hill JC, Watson PJ, Hay EM. Integrating physical and 
psychological approaches to treatment in low back pain: the development and 
content of the STarT Back trial’s ‘high-risk’ intervention (StarT Back; ISRCTN 
37113406) Physiotherapy. 2012: 98 (2): 110-117. 
20 
 
22. The Arthritis Research UK’s advice/exercise sheet 
https://www.arthritisresearchuk.org/arthritis-information/conditions/back-
pain.aspx. Accessed 01.02.2018. 
23. Michaleff ZA, Maher CG, Lin CW, Rebbeck T, Jull G, Latimer J, Connelly L, 
Sterling M. Comprehensive physiotherapy exercise programme or advice for 
chronic whiplash (PROMISE): a pragmatic randomised controlled trial. 2014. 
Lancet. 2014: 384(9938):133-41.  
24. Cote P, Hogg-Johnson S, Cassidy JD, Carroll L, Frank JW & Bombardier C. 
Early aggressive care and delayed recovery from whiplash: isolated finding or 
reproducible result? Arthritis Rheum. 2007; 57(5):861-8. 
25. Cote P, Soklardis S Does early management of whiplash-associated 
disorders assist or impede recovery?. Spine. 2011; 36(25 Suppl):S275-9. 
26. Cassidy JD, Carroll LJ, Côté P, et al. Does multidisciplinary rehabilitation 
benefit whiplash recovery?. Results of a population-based incidence cohort 
study. Spine. 2007; 32:126–3. 
27. Beneciuk JM, Hill JC, Campbell P, Afolabi E, George SZ, Dunn KM, Foster 
NE. Identifying treatment effect modifiers in the StarT Back trial: A secondary 
analysis J Pain. 2017;(1):54-65.  
28. Whitehurst DG, Bryan S, Lewis M, Hill J, Hay EM. Exploring the cost-utility of 
stratified primary care management for low back pain compared with current 
best practice within risk-defined subgroups. Ann Rheum Dis. 2012; 71(11): 
1796-802. 
29. Foster NE, Mullis R, Hill JC, Lewis M, Whitehurst DG, Doyle C, Konstantinou 
K, Main C, Somerville S, Sowden G, Wathall S, Young J, Hay EM on behalf of 
the IMPaCT Back Study team. Effect of stratified care for low back pain in 
family practice (IMPaCT Back): a prospective population-based sequential 
comparison. Annals of Family Medicine. 2014;12(2). 
30. Whitehurst DG, Bryan S, Lewis M, Hay EM, Mullis R, Foster NE 
.Implementing stratified primary care management for low back pain: cost-
utility analysis alongside a prospective, population-based sequential 
comparison study Spine. 2015; 15;40(6):405-14.  
31. Roland M, Morris R. A study of the natural history of back pain. Part I: 
development of a reliable and sensitive measure of disability in low-back pain. 
Spine. 1983;8(2):141-144. 
21 
 
32. Mansell G, Hill JC, Main C, Vowles KE, van der Windt D. Exploring What 
Factors Mediate Treatment Effect: Example of the STarT Back Study High-
Risk Intervention. J Pain. 2016; 17(11): 1237-1245. 
33. Murphy SE, Blake C, Power CK and Fullen BM. The effectiveness of a 
stratified group intervention using the STarTBack screening tool in patients 
with LBP - a non randomised controlled trial. BMC Musculoskeletal Disorders. 
2013; 14:342. 
34. Morsø, L., Kongsted, A., Hestbæk, L. & Kent, P. The prognostic ability of the 
STarT Back Tool was affected by episode duration. European Spine Journal. 
2016; 25 (3):936-944. 
35. Betten C, Sandell C, Hill JC, Gutke A. Cross-cultural adaptation and validation 
of the Swedish STarT Back Screening Tool. European Journal of 
Physiotherapy. European Journal of Physiotherapy. 2015; 17 (1): 29-36. 
36. Aebischer B, Hill JC, Hilfiker R, Karstens S. German Translation and Cross-
Cultural Adaptation of the STarT Back Screening Tool. PLoS One. 2015; 
10;10(7). 
37. Piironen S, Paananen M, Haapea M, Hupli M, Zitting P, Ryynänen K, Takala 
E-P, Korniloff K, Hill JC, Häkkinen A, Karppinen J. Transcultural Adaption and 
Psychometric Properties of the STarT Back Screening Tool among Finnish 
low back pain patients. European Spine Journal. 2015’ ;25(1):287-95. 
38. Bruyère O, Demoulin M, Beaudart C, Hill JC, Maquet D, Genevay S, Mahieu 
G, Reginster JY, Crielaard JM, Demoulin C. Validity and Reliability of the 
French Version of the STarT Back Screening Tool for Patients With Low Back 
Pain. Spine. 2014; 39(2): E123-E128.   
39. Pilz B, Vasconcelos RA, Teixeira PP, Mello W, Marcondes FB, Hill JC, et al. 
Construct and discriminant validity of STarT Back Screening Tool–Brazilian 
version. Brazilian Journal of Physical Therapy. 2017; 21(1),69-73. 
40. Riis A, Rathleff MS, Jensen CE, Jensen MB.. Predictive ability of the start 
back tool: an ancillary analysis of a low back pain trial from Danish general 
practice. BMC Musculoskelet Disord. 2017; 23;18(1):360.. 
41. Campbell P, Hill JC, Protheroe J, Afolabi EK, Lewis M, Beardmore R, Hay 
EM, Mallen CD, Bartlam B, Saunders B, van der Windt DA, Jowett S, Foster 
NE, Dunn KM. Keele Aches and Pains Study protocol: validity, acceptability, 
22 
 
and fesibility of the Keele STaRT MSK tool for subgrouping musculoskeletal 
patients in primary care. J Pain Res. 2016; 9:807-818.  
42. Foster NE, Konstantinou K, Lewis M, Ogollah R, Dunn KM, Hill JC, et al. The 
clinical and cost-effectiveness of stratified care for patients with sciatica: the 
SCOPiC randomised controlled trial protocol (ISRCTN75449581). BMC 
Musculoskeletal Disorders. 2017; 18(1):172. 
43. Morso L, Kent P, Albert HB, Hill JC, Kongsted A, Manniche C: The predictive 
and external validity of the STarT Back Tool in Danish primary care. EurSpine 
J.  2013a; 22(8): 1859–1867. 
44. Morso L, Kent P, Manniche C, Albert HB: The predictive ability of the STarT 
Back Screening Tool in a Danish secondary care setting. EurSpine J 2013b; 
;23(1):120-8. 
45. Morso L, Albert H, Kent P, Manniche C, Hill J: Translation and discriminative 
validation of the STarT Back Screening Tool into Danish. EurSpine J. 2011; 
20(12): 2166–2173. 
46. Beaton DE, Bombardier C, Guillemin F, Ferraz MB: Guidelines for the process 
of cross-cultural adaptation of self-report measures. Spine. 2000; 
25(24):3186-3191. 
47. Ware JE, Jr., Keller SD, Gandek B, Brazier JE, Sullivan M: Evaluating 
translations of health status questionnaires. Methods from the IQOLA project. 
International Quality of Life Assessment. IntJTechnolAssessHealth Care. 
1995; 11(3):525-551. 
48. Lau R, Stevenson F, Ong BN, Dziedzic K, Treweek S, Eldridge S, Everitt H, 
Kennedy A, Qureshi N, Rogers A, Peacock R and Murray E (2016) Achieving 
change in primary care—causes of the evidence to practice gap: systematic 
reviews of reviews. Implementation Science. 2016; 11:40.  
49. Braithwaite J, Marks D, Taylor N Harnessing implementation science to 
improve care quality and patient safety: a systematic review of targeted 
literature. International Journal for Quality in Health Care. 2014; 26 (3):321–
329. 
50. NHS England. National Pathway of Care for Low Back and Radicular Pain 
2017.  
23 
 
51. PHE. Return on investment of interventions for the prevention and treatment 
of musculoskeletal conditions. Public Health England publications gateway 
number:2017209. October, 2017. 
52. KCE Report 287 Low back pain and radicular pain: assessment and 
management. Technical Report. May 2017.  
53. Low back pain: STarTback information leaflet. https://patient.info/health/low-
back-pain-start-back-information-leaflet. Accessed November 2017Red flags 
for back pain. https://www.youtube.com/watch?v=9r4oeZMYqd0. Accessed 
01.02.2017.  
54. Red flags and LBP (https://www.youtube.com/watch?v=9r4oeZMYqd0). 
Accessed 01.02.2017. 
55. The Truth About Back Pain’ 
(http://www.youtube.com/watch?feature=player_embedded&v=ZumxS6DX-
5o)  
56. Buchanan D, Fitzgerald L, Ketley D. The sustainability and spread of 
organisational changes. Modernising Healthcare. 2007. Routledge, Oxon. 
57. Adrian A, Nation A, Durrell S, Andronis L, Rule E, McLeod H. Implementing 
the Keele stratified care model for patients with low back pain: an 
observational impact study. BMC Musculoskeletal Disorders. 2017; 18:66. 
58. Hill JC, Kang S, Benedetto E, et al. Development and initial cohort validation 
of the Arthritis Research UK Musculoskeletal Health Questionnaire (MSK-HQ) 
for use across musculoskeletal care pathways. BMJ Open.  2016; 
6:e012331.doi:10.1136/bmjopen-2016-012331. 
59. Mash B, Fairall L, Adejayan O, Ikpefan O, Kumari J, Mathee S, Okun R, 
Yogolelo A. Morbidity survey of South African primary care PLoS One. 2012; 
7(3):e32358.  
60. Major-Helsloot ME, Crous LC, Grimmer-Somers K, Louw QA. Management of 
LBP at primary care level in South Africa: up to standards? African Health 
Sciences. 2014;14(3):698-706.  
61. Mayosi BM, Lawn JE, van Niekerk A, Bradshaw D, Abdool Karim SS, 
Coovadia HM Lancet South Africa team. Health in South Africa: changes and 
challenges since 2009. Lancet. 2012; 380(9858):2029-43.  
24 
 
62. Negrini S. The possibilities and challenges of "Rehabilitation 2030: a call for 
action" by the World Health Organization: a unique opportunity not to be 
missed. Eur Journal  Physical Rehabilitation Medicine. 2012; 53(2):169-172. 
63. Fairall L, Bateman E, Cornick R, Faris G, Timmerman V, Folb N, Bachmann 
M, Zwarenstein M, Smith R.  Innovating to improve primary care in less 
developed countries: towards a global model. BMJ Innov.  2015; 1(4):196-
203. 
 
